Related Experiment Video

Updated: Jun 12, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Donor influence on outcome in patients undergoing liver transplant for primary biliary cirrhosis

Dietmar A Jacob1, Elena Haase, Fritz Klein

  • 1Department of General, Visceral and Transplantation Surgery, Humboldt University of Berlin, Germany. dr.djacob@web.de

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|June 23, 2010
PubMed

Insights

Donor liver graft histology impacts primary biliary cirrhosis recurrence after liver transplant. Donor factors like fibrosis and fatty degeneration increase recurrence risk, highlighting the need to avoid prolonged donor intensive care.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Immunology

Background:

  • Primary biliary cirrhosis (PBC) is a chronic liver disease.
  • Liver transplantation is a common treatment for end-stage PBC.
  • Donor-specific factors influencing transplant outcomes require further investigation.

Purpose of the Study:

  • To analyze donor-specific histologic factors affecting outcomes after liver transplant for PBC.
  • To identify risk factors for graft recurrence and patient survival post-transplant.

Main Methods:

  • Retrospective analysis of donor data (n=121) and graft histology (n=69) in patients with PBC.
  • Correlation of preoperative donor status and histologic findings with clinical outcomes up to 20 years post-transplant.

Main Results:

  • Donor liver fibrosis, fatty degeneration, and hydrops were associated with increased PBC recurrence risk.
  • Prolonged donor intensive care unit stay, hypotension, and red blood cell administration were linked to poorer patient survival.
  • Donor hypotension and epinephrine administration also correlated with decreased patient survival.

Conclusions:

  • Donor liver graft histology, including inflammation, fibrosis, and fatty degeneration, significantly influences PBC recurrence.
  • Minimizing donor intensive care hospitalization is crucial for improving transplant outcomes.
  • Donor characteristics are critical determinants of long-term success in liver transplantation for PBC.
Abstract

More Related Videos

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...